Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin, Hair, Nail, Gut, and Overall Health Outcomes

12 de noviembre de 2026 actualizado por: The Collagen Co. - GLP-1 Users

This is a single-group, open-label, decentralized clinical trial evaluating the effects of 6 weeks of daily Glow Shakes Premium Collagen Meal Replacement consumption on body composition, weight management, and self-reported health outcomes in 40 adults aged 18-55 years with a BMI between 25-35 kg/m².

All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily, replacing two typical meals, for 6 consecutive weeks. Assessments will be conducted at Baseline, Week 2, Week 4, and Week 6 and will include validated self-report questionnaires and body composition measurements via the Withings smart scale. All study activities are conducted remotely; products are shipped directly to participants' homes and all data are submitted digitally through the Citruslabs study platform.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

40

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Nevada
      • Las Vegas, Nevada, Estados Unidos, 89101
        • Citruslabs

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 55 años (Adulto)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Adults aged 18-55 years at the time of enrollment.
  • BMI between 25-35 kg/m² at screening, as confirmed via participant self-report and/or Withings smart scale measurement at Baseline.
  • Self-reported goals around weight management, body composition improvement, or overall health and wellness at the time of enrollment.
  • Willing and able to use Glow Shakes Premium Collagen Meal Replacement as a daily meal replacement (replacing two typical meals) for 6 consecutive weeks and to complete all questionnaire assessments and Withings smart scale body composition measurements at Baseline, Week 2, Week 4, and Week 6.
  • Willing to maintain current diet (except for the test product), exercise routine, and lifestyle habits for the duration of the 6-week study, without introducing any new supplements or products specifically targeting weight loss, appetite, or body composition.
  • In good general health.
  • Resides in the United States.

Exclusion Criteria:

  • Pregnant or breastfeeding at the time of enrollment, or planning to become pregnant during the 6-week study period.
  • Currently using GLP-1 receptor agonists, dual-incretin medications, prescription weight loss drugs, or any other prescription medication directly affecting appetite or body weight.
  • Known allergy or intolerance to any ingredient in the Glow Shakes formulation, including milk protein, whey protein, or collagen-derived (bovine) ingredients.
  • Diagnosed with a serious medical condition requiring medical nutritional management, including but not limited to Type 1 diabetes, active cancer, or severe renal or hepatic disease.
  • Currently testing, or plan to in the next 6 weeks, a product for another research study.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Glow Shakes Premium Collagen Meal Replacement Arm

All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily (replacing two meals) for 6 weeks. Assessments will be conducted at four timepoints: Baseline, Week 2, Week 4, and Week 6. Assessments will include validated self-report questionnaires and body composition measurements via the Withings smart scale.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Body Weight
Periodo de tiempo: Baseline to Week 6

Change in body weight (kg) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home)

Baseline to Week 6
Change in Body Fat Percentage
Periodo de tiempo: Baseline to Week 6

Change in body fat percentage (%) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home)

Baseline to Week 6

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Self-Reported Weight Management Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported weight management scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Hunger Intensity
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported hunger intensity as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Satiety Duration
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported satiety duration as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Food Craving Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported food craving scores as assessed via the Food Cravings Questionnaire-Trait Reduced (FCQ-T-reduced)

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Skin Health Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported skin health scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Hair Health Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported hair health scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Nail Health Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported nail health scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Change in Self-Reported Gut Comfort and Digestive Symptom Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6

Change from Baseline in self-reported gut comfort and digestive symptom scores as assessed via self-report questionnaire

Baseline, Week 2, Week 4, and Week 6
Participant-Reported Product Satisfaction
Periodo de tiempo: Week 6

Participant-reported product satisfaction, acceptability, and tolerability as assessed via product satisfaction questionnaire

Week 6
Participant-Reported Product Tolerability
Periodo de tiempo: Week 6

Participant-reported tolerability of the study product as assessed via product satisfaction questionnaire

Week 6
Participant-Reported Overall Product Experience
Periodo de tiempo: Week 6

Participant-reported overall experience with the study product as assessed via product satisfaction questionnaire

Week 6

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Colaboradores

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de noviembre de 2026

Finalización primaria (Estimado)

1 de febrero de 2027

Finalización del estudio (Estimado)

1 de febrero de 2027

Fechas de registro del estudio

Enviado por primera vez

12 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Publicado por primera vez (Actual)

18 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

18 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir